Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vibrio cholerae O1 El Tor Inaba is a specific serotype and biotype of the bacterium *Vibrio cholerae*, the causative agent of epidemic cholera. It is characterized by the production of cholera toxin and toxin-coregulated pilus, key virulence factors. Prevention strategies include oral killed whole-cell vaccines and water sanitation.
Oral cholera vaccines induce antibacterial intestinal antibodies preventing bacterial attachment/colonization and anti-toxin antibodies blocking cholera toxin binding to mucosal surfaces.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vibrio cholerae O1 El Tor Inaba (V. cholerae O1 El Tor Inaba).